MALLINCKRODT GROUP INC
8-K, 1995-11-22
PHARMACEUTICAL PREPARATIONS
Previous: MALLINCKRODT GROUP INC, 8-K, 1995-11-22
Next: IES UTILITIES INC, S-3/A, 1995-11-22



          UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                                  
                                  
                                  
                      Washington, D.C.  20549
                                  
                                  
                                  
                              FORM 8-K
                                  
                                  
                           CURRENT REPORT
                                  
                                  
                                  
               Pursuant to Section 13 or 15(d) of the
                  Securities Exchange Act of 1934
                                  
                                  
                                  
                         November 22, 1995
                                  
                                  
                                  
                                  
                      Mallinckrodt Group Inc.
       (Exact name of registrant as specified in its charter)
                                  
                                  
                                  
                                  
           New York                1-483              36-1263901
(State or other jurisdiction    (Commission       (I.R.S. Employer
       of incorporation)         File Number)    Identification No.)


7733 Forsyth Boulevard, St. Louis, MO                 63105-1820
(Address of principal executive offices)              (ZIP Code)


Registrant's telephone number,                      (314) 854-5200
     including area code

















<PAGE>
Item 5.  Other Events

Following are the Mallinckrodt Group Inc. fiscal 1995 and 1994 income
statements as restated for the sale of the Feed Ingredients business.

<TABLE>
<CAPTION>
MALLINCKRODT GROUP INC.
RESTATED INCOME STATEMENT ($ IN MILLIONS)

                                        Fiscal 1995
                          -------------------------------------    Fiscal
                           Qtr 1     Qtr 2     Qtr 3     Qtr 4      1995
                          -------   -------   -------   -------   -------- 
<S>                       <C>       <C>       <C>       <C>       <C>
NET SALES
  Mallinckrodt Chemical   $110.7    $121.8    $159.2    $185.1    $  576.8
  Mallinckrodt Medical     229.8     240.4     255.5     286.1     1,011.8
  Mallinckrodt Veterinary  108.3     109.3     114.6     122.7       454.9
  Intersegment Sales         (.2)                (.1)                  (.3)
                          -------   -------   -------   -------   ---------
                          $448.6    $471.5    $529.2    $593.9    $2,043.2
                          =======   =======   =======   =======   =========

OPERATING EARNINGS
  Mallinckrodt Chemical   $  6.6    $ 15.2    $ 20.3    $ 26.4    $   68.5
  Mallinckrodt Medical      50.9      51.4      57.6      68.3       228.2
  Mallinckrodt Veterinary    4.2       5.8       8.4      10.3        28.7
  Corporate                 (6.2)     (7.4)     (6.6)     (8.5)      (28.7)
                          -------   -------   -------   -------   ---------
                          $ 55.5    $ 65.0    $ 79.7    $ 96.5    $  296.7
                          =======   =======   =======   =======   =========

Net Sales                 $448.6    $471.5    $529.2    $593.9    $2,043.2

Operating costs and 
  expenses:
  Cost of goods sold       248.3     250.0     286.9     317.6     1,102.8
  Selling, administrative
    and general expense    123.7     133.8     138.3     157.0       552.8
  Research and 
    development expense     23.2      24.5      23.6      26.5        97.8
  Other operating (income)
    expense, net            (2.1)     (1.8)       .7      (3.7)       (6.9)
                          -------   -------   -------   -------   ---------
                           393.1     406.5     449.5     497.4     1,746.5
                          -------   -------   -------   -------   ---------
Operating earnings          55.5      65.0      79.7      96.5       296.7
Equity in pre-tax earnings
  of joint venture           6.1       4.1       6.3       8.8        25.3
Interest and other non-
  operating expense, net     (.3)      (.5)      (.2)     (3.3)       (4.3)
Interest expense           (12.0)    (11.8)    (17.7)    (14.0)      (55.5)
                          -------   -------   -------   -------   ---------
Earnings from continuing
  operations before
  income taxes              49.3      56.8      68.1      88.0       262.2
Income tax provision        18.8      21.5      25.0      33.0        98.3
                          -------   -------   -------   -------   ---------
Earnings from
  continuing operations     30.5      35.3      43.1      55.0       163.9
Discontinued operations      3.4       4.5       3.9       4.6        16.4
                          -------   -------   -------   -------   ---------
Net earnings                33.9      39.8      47.0      59.6       180.3
Preferred stock dividends    (.1)      (.1)      (.1)      (.1)        (.4)
                          -------   -------   -------   -------   ---------
Available for common
  shareholders            $ 33.8    $ 39.7    $ 46.9    $ 59.5    $  179.9
                          =======   =======   =======   =======   =========
Earnings Per Common Share
  Continuing operations    $.40      $.45      $.56      $.70      $2.11
  Discontinued operations   .04       .06       .05       .06        .21
                          -------   -------   -------   -------   ---------
  Net earnings             $.44      $.51      $.61      $.76      $2.32
                          =======   =======   =======   =======   =========
</TABLE>

<PAGE>
<TABLE>
<CAPTION>
MALLINCKRODT GROUP INC.
RESTATED INCOME STATEMENT ($ IN MILLIONS)

                                        Fiscal 1994
                          -------------------------------------    Fiscal
                           Qtr 1     Qtr 2     Qtr 3     Qtr 4      1994
                          -------   -------   -------   -------   -------- 
<C>                       <S>       <S>       <S>       <S>       <S>
NET SALES
  Mallinckrodt Chemical   $102.5    $101.6    $111.3    $121.5    $  436.9
  Mallinckrodt Medical     200.9     225.5     222.7     263.2       912.3
  Mallinckrodt Veterinary  103.5      95.9     111.4     118.7       429.5
  Intersegment Sales         (.7)                          (.1)        (.8)
                          -------   -------   -------   -------   ---------
                          $406.2    $423.0    $445.4    $503.3    $1,777.9
                          =======   =======   =======   =======   =========

OPERATING EARNINGS (LOSS)
  Mallinckrodt Chemical   $  8.0    $ 11.4    $ 17.6    $ 24.7    $   61.7
  Mallinckrodt Medical      46.7      47.5      47.3     (12.6)      128.9
  Mallinckrodt Veterinary    5.9       2.8       7.7     (15.4)        1.0
  Corporate                 (7.7)     (5.8)     (7.6)     (9.1)      (30.2)
  Eliminations                .1                                        .1
                          -------   -------   -------   -------   ---------
                          $ 53.0    $ 55.9    $ 65.0    $(12.4)   $  161.5
                          =======   =======   =======   =======   =========

Net Sales                 $406.2    $423.0    $445.4    $503.3    $1,777.9

Operating costs and 
  expenses:
  Cost of goods sold       217.7     224.3     229.9     260.0       931.9
  Selling, administrative
    and general expense    115.6     119.4     126.0     135.7       496.7
  Research and 
    development expense     21.1      23.2      24.1      26.9        95.3
  Restructuring charge                                    93.9        93.9
  Other operating (income)
    expense, net            (1.2)       .2        .4       (.8)       (1.4)
                          -------   -------   -------   -------   ---------
                           353.2     367.1     380.4     515.7     1,616.4
                          -------   -------   -------   -------   ---------
Operating earnings (loss)   53.0      55.9      65.0     (12.4)      161.5
Equity in pre-tax earnings
  of joint venture           3.8       3.2       4.8       6.7        18.5
Interest and other non-
  operating income
  (expense), net             (.6)       .4        .8      (1.0)        (.4)
Interest expense            (8.6)     (9.5)    (10.4)    (11.5)      (40.0)
                          -------   -------   -------   -------   ---------
Earnings (loss) from 
  continuing operations 
  before income taxes       47.6      50.0      60.2     (18.2)      139.6
Income tax provision
  (benefit)                 17.1      19.5      21.9      (6.8)       51.7
                          -------   -------   -------   -------   ---------
Earnings (loss) from
  continuing operations     30.5      30.5      38.3     (11.4)       87.9
Discontinued operations      4.0       5.5       4.0       2.4        15.9
                          -------   -------   -------   -------   ---------
Net earnings (loss)         34.5      36.0      42.3      (9.0)      103.8
Preferred stock dividends    (.1)      (.1)      (.1)      (.1)        (.4)
                          -------   -------   -------   -------   ---------
Available for common
  shareholders            $ 34.4    $ 35.9    $ 42.2    $ (9.1)   $  103.4
                          =======   =======   =======   =======   =========
Earnings (Loss) Per 
  Common Share
  Continuing operations    $.39      $.39      $.49      $(.15)     $1.13
  Discontinued operations   .05       .07       .05        .03        .20
                          -------   -------   -------   -------   ---------
  Net earnings (loss)      $.44      $.46      $.54      $(.12)     $1.33
                          =======   =======   =======   =======   =========

</TABLE>

MALLINCKRODT GROUP INC.



ROGER A. KELLER
Vice President, Secretary 
  and General Counsel

DATE:  November 22, 1995


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission